- The Effect of Inflammatory Markers on Survival in Advanced Biliary Tract Carcinoma Treated with Gemcitabine/Oxaliplatin RegimenMahmut, Buyuksimsek; Mehmet Mutlu, Kidi; Ali, Ogul; Cem, Mirili; Semra, PaydasJournal of Gastrointestinal Cancer, 2021, 52(1): 249-255.被引 1
- Efficacy and safety of durvalumab plus gemcitabine and cisplatin in Chinese participants with advanced biliary tract cancer: Extension cohort of the phase III, randomised, double-blind, placebo-controlled, global TOPAZ-1 studyQin, S.; Cai, J-Q.; Li, E.; Xing, B.; Zhao, L.; Dai, C.; Li, J.; Shen, Y.; Chen, Z.; Liu, L.; Lu, Z.; Zang, A.; Bai, Y.; Liang, H.; Liang, J.; Liu, X.; Wang, J.; Chen, M-H.; Miao, R.; Qu, X.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
- ASO Visual Abstract: Adjuvant Chemotherapy for Patients with Adenocarcinoma of the Esophagogastric Junction: A Retrospective, Multicenter Observational StudyNie, Run-Cong; Luo, Tian-Qi; Li, Guo-Dong; Zhang, Fei-Yang; Chen, Guo-Ming; Li, Jin-Xing; Chen, Xiao-Jiang; Zhao, Zhou-Kai; Jiang, Kai-Ming; Wei, Yi-Cheng; Hang, Ming-Wei*; Chen, Shi*; Chen, Ying-Bo*Annals of Surgical Oncology, 2023.
期刊论文
Phase 2 Trial of Adjuvant Chemotherapy With S − 1 for Node-Positive Biliary Tract Cancer (N-SOG 09)
3被引13阅读
